| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |